NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity‐modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer
暂无分享,去创建一个
B. Erickson | W. Bosch | W. Small | Ying Xiao | U. Matulonis | D. Gaffney | N. Horowitz | R. Mannel | L. Souhami | L. Portelance | A. Viswanathan | A. Jhingran | J. Moughan | K. Winter | B. Miller | B. Miller